Trade Summary

4 days ago, Sweeny Nicole, serving as Chief Commercial Officer at Kalvista Pharmaceuticals, Inc. (KALV), sold 3,975 shares at $15.57 per share, for a total transaction value of $61,878.00. Following this transaction, Sweeny Nicole now holds 47,003 shares of KALV.

This sale represents a 8.00% decrease in Sweeny Nicole's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, February 23, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, February 24, 2026, 1 day after the trade was made.

Kalvista Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.